Industry Overview

Global brucellosis vaccine market was valued at USD 268.3 Mn in 2020 and is expected to grow at a CAGR of 4.2% during 2021–2030 to reach 378.2 Mn by the year 2030.

The market growth is accounted for growing awareness about the animal disease and R&D investment by major market players which is expected to boost the demand over the forecast period.

Introduction

Brucellosis is a very contagious zoonotic infection. Brucella is spread from animals to people by consuming contaminated foods, undercooked meat, or unpasteurized milk from ill animals; direct contact with infected animals or their discharges; and inhalation of aerosols. For brucellosis, vaccines such as the RB51 vaccine and the S19 vaccine are available. The worldwide brucellosis vaccine market is fueled by rising brucellosis prevalence and increased government spending.

Brucellosis Vaccine Market Covid-19 Pandemic Impact & Recovery Analysis

During COVID-19, out-of-hospital care is expected to increase significantly. Stakeholders in the brucellosis vaccine market are expanding the number of home healthcare providers, rehab centers, and long-term care facilities available. In-patient and community-based doctors should assess existing patient capacity in both settings and prepare for pandemic-like scenarios in the future.

To enhance patient outcomes and fulfill demand, companies in the brucellosis vaccine industry are working to maintain solid supply chains. Companies are searching for government funding and arranging staff wellness programs to avoid and minimize burnout, as well as comparing salary and benefits to the industry standard. Clinical research and clinical trial operations that have been disrupted are now being undertaken via telemedicine options wherever possible.

Know how Covid-19 pandemic affected market growth: Order Free Sample & Covid-19 pandemics impact & recovery analysis

Brucellosis Vaccine Market Dynamics

Increased Government Investments and a Rise in Brucellosis Prevalence

The expansion of the animal healthcare industry is heavily influenced by government policies. The global veterinary healthcare market is likely to be driven by factors such as China’s obligatory vaccination policy, public awareness campaigns, the availability of low-cost veterinary vaccines, and funding for research and development. The Animal and Plant Health Agency (APHA) won the AgResults Brucellosis Vaccine Prize, which was designed to encourage the discovery of a vaccine that is efficient, safe, and viable for use against Brucella melitensis in small ruminants in developing countries.

From 2021 to 2030, the worldwide brucellosis vaccine market is expected to rise due to an increase in the number of animals infected with the disease. Animal illnesses spread as a result of globalization and climate change, and some of these diseases are transmissible to people. According to the IFAH Europe, rising global temperatures cause the emergence of new diseases and aid the reemergence of old ones. The majority of human zoonotic illnesses are spread by animals. Zoonotic illnesses are responsible for 61% of all animal diseases. In the coming years, rising livestock populations in nations like China and India are expected to fuel demand for brucellosis vaccines.

Rising awareness about animal diseases

Livestock owners must be aware of animal illnesses, their symptoms, and treatments. To raise public knowledge, several animal health awareness campaigns have been implemented. The National Animal Disease Control Programme (NADCP) in India is a flagship scheme launched by the Honorable Prime Minister in September 2019 to control foot and mouth disease and brucellosis by vaccinating 100 %of cattle, buffalo, sheep, goat, and pig populations against FMD and 100 % of bovine female calves aged four to eight months against brucellosis.

Know how the market dynamics are projected to shift: Order Free Sample & Competition Landscape Mapping

Brucellosis Vaccine Market Segment Analysis

The Brucellosis Vaccine market is segmented by type, by vaccine type, by application, by distribution channel, & by region.

Insights by Type

The global brucellosis vaccine market is divided into three types: RB51 vaccine, S19 vaccine, and others. In 2020, the worldwide brucellosis vaccine market was led by the RB51 vaccine segment, and this trend is likely to continue over the forecast period. The RB51 vaccine is the most often used brucellosis vaccination.

Pregnant cows who are vaccinated with strain RB51 have a low risk of abortion (less than 0.2 %), although it is safe at lower dosages during pregnancy. During the projected period, this is anticipated to push the segment ahead. In the next years, the market is expected to grow owing to a rise in preference for the RB51 vaccine over others because of its high effectiveness in low doses.

Insights by Vaccine Type

Based on the vaccine type, the global brucellosis vaccine market has been categorized into subunit vaccine, DNA vaccine, recombinant vaccine, and vector vaccine. In terms of revenue, the DNA vaccine category led the worldwide brucellosis vaccine market in 2020, and this trend is expected to continue over the forecast period. DNA vaccination provides a novel and beneficial method to the creation of brucellosis vaccines, with benefits in design flexibility, speed, and production simplicity, as well as the capacity to elicit both cellular and humoral immune responses. During the forecast period, this aspect is likely to propel the segment’s expansion in the brucellosis vaccine market.

Insights by Application

The worldwide brucellosis vaccine market is divided into cattle, sheep and goat, and other applications. Due to the widespread use of these vaccinations for cattle, this category is expected to have a considerable market share over the projection period.

Furthermore, the category is expected to grow in the coming years as the population of cattle in nations like India and Brazil grows. Brazil will have around 147 million cattle in 2020, according to research.

Insights by Distribution Channel

The brucellosis vaccine market has been segmented by distribution channel into retail channels, veterinary hospitals & clinics, and others. In terms of revenue, the veterinary hospitals and clinics sector led the brucellosis vaccine market in 2020. The trend is expected to continue over the projection period, owing to an increase in owners’ willingness to use veterinary clinics for different vaccinations and a preference for veterinary hospitals and clinics for vaccination.

Know how the key market segments are projected to drive overall growth over the forecast period: Order Free Sample Report

Brucellosis Vaccine Market Regional Analysis

In 2020, Asia Pacific was the largest market for brucellosis vaccines, followed by Europe. The substantial market share held by the Asia Pacific is attributed to an increase in cattle population, and growing brucellosis cases and the market share held by the Asia Pacific is attributed to an increase in cattle population, and growing brucellosis cases.

From 2021 to 2030, the brucellosis vaccine market in the Asia Pacific is expected to grow at a high pace. This is due to the existence of developing economies with commercial centers, increasing large corporations, improved healthcare infrastructure, and higher corporate investment.

Know how MICRO & MACRO factors are impacting the regional growth: Order Free Sample Report

Competitive Insights

The brucellosis vaccine market is projected to register significant competition in the coming years with new market entrants competing with prominent players by leveraging R&D to develop new technologies.

Major companies in the brucellosis vaccine market include (Direct & Indirect Competitors):

• Merck Animal Health
• Ceva Sante Animale
• CZ Vaccines
• Fivet Animal Health
• Jordan Bio-industries Center
• Laboratories Tornel
• Colorado Serum Company
• Indian Immunologicals Ltd.
• Hester Biosciences Limited
• Veterinary Technologies Corporation
• Others (20+ Companies are profiled in the final report)

Recent Market Developments:

• 17 June 2020: Merck Animal Health announced the completion of its acquisition of Quantified Ag®, a leading data and analytics company that monitors cattle body temperature and movement to detect illness early. In April 2018, Merck Animal Health invested in Quantified Ag® and partially funded their development work in data analytics in livestock
• 2 December 2020: Colorado Serum Company completed investment….
• 13 May 2021: Hester Biosciences Limited announced…

Know-how key market developments are projected to impact the future growth: Order Free Competition Landscape Mapping

Brucellosis Vaccine Market Report Coverage

Global Brucellosis Vaccine Market, by Type

• RB51 Vaccine
• S19 Vaccine
• Others

Global Brucellosis Vaccine Market, by
Vaccine Type

• Vector Vaccine
• DNA Vaccine
• Subunit Vaccine
• Recombinant Vaccine

Global Brucellosis Vaccine Market, by
Application

• Cattle
• Sheep & Goat
• Others

Global Brucellosis Vaccine Market, by
Application

• Veterinary Hospitals & Clinics
• Retail Channels
• Others

Global Brucellosis Vaccine Market, by Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • South Korea
  • Japan
  • India
  • China
  • Australia
  • Malaysia
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
• South America
  • Brazil
  • Argentina